Bacil Pharma

35.80
0.00
(0.00%)
Market Cap
21.10 Cr
EPS
0.69
PE Ratio
51.88
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
62.56
52 Week Low
14.85
PB Ratio
1.22
Debt to Equity
0.05
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,682.60
#1 4,01,168.80
35.03
#1 54,729.00
12.06
#1 10,980
-18.99
52.11
6,778.50
1,81,447.80
82.80
9,360.00
0.89
2,117
23.05
53.82
1,484.00
1,19,944.60
23.31
28,409.50
7.12
5,291
30.28
44.66
3,404.90
1,12,167.60
58.54
11,539.40
11.59
1,911
10.91
62.33
2,696.50
1,06,413.90
53.56
12,207.40
19.57
1,925
-10.91
76.79
1,250.60
1,04,713.60
#1 18.86
33,741.20
12.36
5,725
21.14
38.64
968.45
98,570.70
21.11
22,573.80
13.82
3,977
-0.19
49.02
1,926.10
86,530.10
26.34
22,192.10
#1 19.94
3,024
#1 112.49
44.79
34,295.00
73,140.10
51.70
6,409.15
10.80
1,417
27.83
59.37
1,138.60
65,328.60
18.90
31,378.10
17.55
3,366
-0.50
48.47
Forecast
Actual
Growth Rate
Revenue Growth
-
Net Income Growth
-
Cash Flow Change
100.00 %
ROE
-
ROCE
-
EBITDA Margin (Avg.)
-

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Revenue
0
0
0
0
0
0
0
0
0
0
0
Expenses
0
0
0
0
0
1
0
4
0
0
0
EBITDA
0
-0
0
0
-0
-0
-0
-4
-0
-0
-0
Operating Profit %
0 %
0 %
0 %
0 %
0 %
0 %
0 %
0 %
0 %
0 %
0 %
Depreciation
0
0
0
0
0
0
0
0
0
0
0
Interest
0
0
0
0
0
0
0
0
0
0
0
Profit Before Tax
0
-0
0
-4
-0
-0
-0
-4
-0
-0
0
Tax
0
0
0
0
0
0
0
0
0
0
0
Net Profit
0
-0
0
-4
-0
-0
-0
-4
-0
-0
0
EPS in ₹
-0.05
-0.11
0.00
-6.37
-0.58
-0.54
-0.41
-6.55
-0.17
-0.10
0.69

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
7
7
7
5
5
4
4
1
1
1
26
Fixed Assets
0
5
6
3
3
3
3
0
0
0
0
Current Assets
1
0
0
1
1
0
0
0
0
0
3
Capital Work in Progress
6
0
0
0
0
0
0
0
0
0
0
Investments
0
0
1
1
1
0
0
0
0
1
0
Other Assets
1
1
0
1
1
1
1
1
1
1
0
Total Liabilities
7
7
7
5
5
4
4
1
1
1
26
Current Liabilities
0
0
0
3
3
3
3
0
0
0
0
Non Current Liabilities
0
0
0
0
0
0
0
0
0
0
0
Total Equity
7
6
6
2
2
1
1
1
1
1
25
Reserve & Surplus
-0
-0
-0
-4
-5
-5
-5
-5
-5
-5
12
Share Capital
7
7
7
7
7
7
7
7
7
7
14

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-0
0
0
0
-0
-0
0
0
-0
0
Investing Activities
-0
-0
0
-1
0
0
1
4
-0
0
Operating Activities
0
0
0
1
-0
-0
-0
-4
-0
0
Financing Activities
0
0
0
0
-0
-0
-0
0
0
-0

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Promoter
42.67 %
42.67 %
42.67 %
42.67 %
42.67 %
42.67 %
42.67 %
42.67 %
42.67 %
42.67 %
42.67 %
42.67 %
42.67 %
42.67 %
20.70 %
10.60 %
0.20 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
51.38 %
53.85 %
53.88 %
52.88 %
52.83 %
52.90 %
53.74 %
53.77 %
53.76 %
53.79 %
53.80 %
53.77 %
53.89 %
53.91 %
59.61 %
67.42 %
75.77 %
Others
5.95 %
3.48 %
3.45 %
4.45 %
4.50 %
4.43 %
3.59 %
3.56 %
3.57 %
3.54 %
3.53 %
3.56 %
3.44 %
3.42 %
19.69 %
21.98 %
24.03 %
No of Share Holders
0
6,410
6,319
6,461
6,514
6,532
6,545
6,548
6,649
6,663
6,647
6,628
6,770
6,794
6,902
7,461
7,638

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
26 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
26 May 2025 43.70 43.70
21 Jan 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
21 Jan 2025 46.26 42.55
14 Nov 2024 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
14 Nov 2024 37.97 48.04
23 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
23 Oct 2024 35.09 38.72
27 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
27 Sept 2024 21.11 27.73

Announcements

Board Meeting Intimation for We Wish To Inform You That The Meeting Of Board Of Directors Scheduled To Be Held On Wednesday 16Th July 20253 days ago
Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)3 days ago
Closure of Trading WindowJun 26, 2025
Receipt Of Listing Approval Granted By Stock Exchange For 8463000 Equity Shares Of Rs.10/- Each Issued At A Premium Of Rs.22/- Issued To Non- Promoter On Preferential BasisJun 05, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 27, 2025
Revised Audited Financial Result For The Quarter And Year Ended 31St March 2025May 26, 2025
Revised Outcome Of Board Meeting Held On 26Th May 2025 For Audited Financial Result For The Quarter And Year Ended 31St March 2025May 26, 2025
Results-Financial Results For The Year Ended 31/03/2025May 26, 2025
Board Meeting Outcome for Outcome Of Board Meeting For Approval Of Audited Financials For The Year Ended 31St March2025May 26, 2025
Board Meeting Intimation for We Wish To Inform That The Meeting Of The Board Of Directors Of The Company Is Scheduled To Be Held On Monday 26Th May 2025May 17, 2025
Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2Apr 23, 2025
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 23, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 11, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 28, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 28, 2025
Closure of Trading WindowMar 27, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 27, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 27, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 27, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 26, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 26, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 26, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 26, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 25, 2025
Board Meeting Outcome for Outcome Of The Preferential Allotment Committee (The Committee) Held On 24Th March 2025Mar 24, 2025
Announcement under Regulation 30 (LODR)-AllotmentMar 24, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 24, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 21, 2025
Announcement under Regulation 30 (LODR)-AllotmentMar 12, 2025
Board Meeting Outcome for Outcome Of The Preferential Allotment Committee (The Committee) Held On 12Th March 2025 For Allotment Of 6580500 Equity Shares To Non-Promoters On A Preferential Basis Pursuant To Share SwapMar 12, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 12, 2025
In-Principle Approval Granted By Stock ExchangeMar 11, 2025
In-Principle Approval Granted By Stock ExchangeMar 11, 2025
Integrated Filing (Financial)Mar 11, 2025
Announcement under Regulation 30 (LODR)-Resignation of DirectorFeb 25, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 23, 2025
Outcome Of Board MeetingJan 21, 2025
Board Meeting Outcome for Outcome Of Board MeetingJan 21, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 17, 2025
Board Meeting Intimation for 1) To Consider And Approve The Un-Audited Financial Results Along With Limited Review Report Of The Company For The Quarter Ended 31St December 2024. 2) Other Routine BusJan 13, 2025
Closure of Trading WindowDec 28, 2024
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011Dec 03, 2024
Shareholder Meeting / Postal Ballot-Scrutinizers ReportNov 18, 2024
Shareholder Meeting / Postal Ballot-Outcome of EGMNov 14, 2024
Corrigendum To The Notice Of The EOGM Dated 15/10/2024Nov 12, 2024
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011Nov 12, 2024
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011Nov 11, 2024
EXTRA-ORDINARY GENERAL MEETING ('EOGM') OF THE MEMBERS OF BACIL PHARMA LIMITED WILL BE HELD ON THURSDAY, NOVEMBER 14, 2024 AT 11:00 AM THROUGH VIDEO CONFERENCING ('VC')/OTHER AUDIO VISUAL MEANS ('OAVM')Oct 23, 2024
Outcome Of Board Meeting Held On 23Rd October 2024Oct 23, 2024
Board Meeting Outcome for Outcome Of Board MeetingOct 23, 2024

Technical Indicators

RSI(14)
Neutral
37.08
ATR(14)
Less Volatile
4.91
STOCH(9,6)
Neutral
33.87
STOCH RSI(14)
Oversold
0.00
MACD(12,26)
Bearish
-0.70
ADX(14)
Weak Trend
24.58
UO(9)
Bearish
78.77
ROC(12)
Downtrend But Slowing Down
-13.73
WillR(14)
Neutral
-22.00